Israeli AI drug discovery company Quris has raised an additional USD 9 million in seed funding, bringing total seed round funding to USD 37 million. The round was led by SoftBank Vision Fund 2 along with existing private and institutional investors including Welltech Ventures. The latest addition follows the USD 19 million raised in January 2022 and the initial USD 9 million raised in October 2021.
The proceeds will be directed toward advancing its Bio-AI platform, accelerating its research and development of novel therapeutics, expanding its team, and enhancing partnerships.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.